CNTB

Connect Biopharma Holdings Limited Ordinary Shares

2.46

USD

CNTB Earnings Reports

Positive Surprise Ratio

CNTB beat 4 of 4 last estimates.

100%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Connect Biopharma Holdings Limited Ordinary Shares earnings per share and revenue

On Nov 12, 2025, CNTB reported earnings of -0.31 USD per share (EPS) for Q3 25, beating the estimate of -1.01 USD, resulting in a 69.43% surprise. Revenue reached 16.00 thousand, compared to an expected --, with a 0.00% difference. The market reacted with a +5.92% price change (close before vs. close after earnings).

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

Regeneron Pharmaceuticals Inc

Report Date

Jan 30, 2026 For Q4 25

Estimate

$10.84

Actual

$11.44

Surprise

+5.52%

Twist Bioscience Corporation Common Stock

Report Date

Feb 02, 2026 For Q1 26

Estimate

-$0.43

Actual

-$0.50

Surprise

-14.00%

FAQ

What were Connect Biopharma Holdings Limited Ordinary Shares's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Connect Biopharma Holdings Limited Ordinary Shares reported EPS of -$0.31, beating estimates by 69.43%, and revenue of $16.00K, 0% as expectations.

How did the market react to Connect Biopharma Holdings Limited Ordinary Shares's Q3 2025 earnings?

The stock price moved up 5.92%, changed from $1.52 before the earnings release to $1.61 the day after.

When is Connect Biopharma Holdings Limited Ordinary Shares expected to report next?

The next earning report is scheduled for --.

What are the forecasts for Connect Biopharma Holdings Limited Ordinary Shares's next earnings report?

Based on -- analysts, Connect Biopharma Holdings Limited Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.